Articles  |   September 2013
ACE Question
Article Information
Education / CPD / Articles
Articles   |   September 2013
ACE Question
ASA Monitor 09 2013, Vol.77, 52.
ASA Monitor 09 2013, Vol.77, 52.
You are preparing to provide an awake intubation and general anesthesia to a 64-year-old smoker with a history of extremely difficult tracheal intubation. Shortly after achieving topicalization of the airway with 20% benzocaine spray, the patient starts complaining of dyspnea and lightheadedness. His oxygen saturation measured by pulse oximetry declines to 84 percent and remains at that level despite the administration of 100 percent oxygen by facemask. Administration of which of the following would be the MOST appropriate therapy?
Benzocaine, available in 10 percent, 15 percent, and 20 percent solutions, is an ethyl ester of para-aminobenzoic acid; it is water soluble and widely used for topicalization of the airway during awake intubation. The 20 percent benzocaine solution contains 200 mg/mL, which can deliver between 60 mg (0.3 mL) to more than 200 mg (>1 mL) with every 1 second spray. Benzocaine is a component in Cetacaine, which contains 14 percent benzocaine, 2 percent tetracaine, and 2 percent butyl aminobenzoate. Benzocaine topicalization is associated with the development of methemoglobinemia. It has been recommended that the maximum dose of benzocaine for airway topicalization be limited to less than 1.5 mg/kg. Doses as small as 100 mg in adult patients can cause methemoglobinemia, especially in susceptible individuals.
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Affiliation & Institution
I have a potential conflict of interest
Comment Title

This feature is available to Subscribers Only
ASA Member Login or Create an Account ×